Accepted for/Published in: JMIR Research Protocols
Date Submitted: Jul 24, 2024
Date Accepted: Feb 27, 2025
Warning: This is an author submission that is not peer-reviewed or edited. Preprints - unless they show as "accepted" - should not be relied on to guide clinical practice or health-related behavior and should not be reported in news media as established information.
A Virtual Diabetes Prevention Program tailored to increase participation of Black and Latino Men: Protocol for a Randomized Controlled Trial
ABSTRACT
Background:
A clinic-based National Diabetes Prevention Program (NDPP) tailored to Black and Latino men has the potential to address prior limitations of NDPP implementation and reduce gender-based diabetes disparities.
Objective:
This study was designed to 1) Assess the effect of Power-Up (a men-centered virtual NDPP program) vs. standard care, mixed-gender virtual NDPP on percent weight loss among racial and ethnic minority men at risk for diabetes; 2) Compare engagement of racial and ethnic minority men at risk for diabetes in Power-Up vs. standard care NDPP; and 3) Evaluate the reach, effectiveness, adoption, implementation, and costs of Power-Up. We hypothesize that men randomized to Power-Up will achieve significantly greater weight loss (% weight loss from baseline) at 16-weeks and 1-year than men randomized to the standard, mixed-gender NDPP group. Men randomized to Power-Up will also have significantly greater engagement and retention than men randomized to the standard care NDPP.
Methods:
Using the electronic health record (EHR) systems of a large academic medical center and a network of small to medium independent primary care practices throughout New York City, we identified Black and Latino men that meet the eligibility criteria for NDPP.
Results:
We enrolled 301 participants through our health system partners. Men were randomized 1:1 to either the Power-Up intervention arm or to a standard, mixed-gender NDPP.
Conclusions:
This manuscript describes the Power-Up trial design and allocation of participants to NDPP groups. Clinical Trial: ClinicalTrials.gov NCT04104243
Citation
Request queued. Please wait while the file is being generated. It may take some time.
Copyright
© The authors. All rights reserved. This is a privileged document currently under peer-review/community review (or an accepted/rejected manuscript). Authors have provided JMIR Publications with an exclusive license to publish this preprint on it's website for review and ahead-of-print citation purposes only. While the final peer-reviewed paper may be licensed under a cc-by license on publication, at this stage authors and publisher expressively prohibit redistribution of this draft paper other than for review purposes.